Regeneron price for 23andMe spread over the users who paid for the ancestry test (arithmetic over two stated numbers)
$256 million
USD per 23andMe user (consumer DNA array record), US
“Regeneron Pharmaceuticals purchased the collapsed genetic testing firm for $256 million...Many of the 15 million users who paid the company for the initial ancestry test”
Quartz, 23andMe just got bought out of bankruptcy (May 2025), 2025-05
- Kind of source
- Named press report
- Read on
- 2026-11-06
- Daily check
- Source re-read on 2026-11-06 needs a browser (PDF or protected page)
- What to know
- Whole-company distressed sale, so this per-user figure includes the brand, lab and biobank and is a low anchor, not a per-record data price.
- Arithmetic
- $256,000,000 / 15,000,000 users = $17.07 per user.
- About
- Consumer DNA test